Artikelen

SELECTIE ARTIKELEN UIT 2025

Adriaens N, Bouwman FM, Bruisten SM, Vergunst CE, van Dam AP, Doelman TA, Westerhuis BM. Mycoplasma genitalium molecular typing in men with non-gonococcal urethritis discriminates between phylogenetic clusters based on sexual preference and antibiotic resistance. J Med Microbiol. 2025 Apr;74(4):001999. doi: 10.1099/jmm.0.001999. PMCID: PMC12032421.  
Baum JHJ, Dörre A, Boender TS, Heldt K, Wilking H, Drynda S, Erdmann B, Grashey R, Grupp C, Habbinga K, Hamelmann E, Heining A, Höger-Schmidt H, Kill C, Reichert F, Riße J, Schilling T; AKTIN Research Group; Schranz M. Establishing and validating syndromic surveillance of gastrointestinal infections using routine emergency department data, Germany, 2019-2023. Sci Rep. 2025 Nov 3;15(1):38281. doi: 10.1038/s41598-025-13675-z. PMCID: PMC12583625.
Birnie E, Vergouwe M, Appelman B, Biemond JJ, Heijmans J, Nichols BE, Wiersinga WJ, Popping S; TURN-COVID studygroup. Cost-effectiveness Analysis of Nirmatrelvir/Ritonavir for COVID-19 Among Individuals at High Risk: A Modeling Study. Open Forum Infect Dis. 2025 Mar 26;12(4):ofaf187. doi: 10.1093/ofid/ofaf187. PMCID: PMC12006789. Maarten Schim van der Loeff: Turn-Covid studygroep
Bolluyt DC, van den Elshout MAM, Wijstma ES, Boyd A, Hoornenborg E, De Vries HJC, Prins M, Vogt L, Schim van der Loeff MF; Amsterdam PrEP Project Team in the HIV Transmission Elimination AMsterdam Initiative (H-TEAM). Renal Outcomes Over the Course of 5 Years of Oral HIV Preexposure Prophylaxis Using Tenofovir Disoproxil/Emtricitabine. Kidney Int Rep. 2025 Mar 25;10(6):2003-2014.  doi: 10.1016/j.ekir.2025.03.033. PMCID: PMC12231006.
Bosdriesz JR, den Boogert EM, van Dijken S, Dukers-Muijrers NHTM, Götz HM, Goverse IE, Leenstra T, Petrignani MWF, Raven SFH, van der Loeff MFS, van den Hof S, Wevers K, Matser AA. The influence of case factors and system factors on the timeliness of testing and contact tracing for COVID-19 in The Netherlands. Eur J Public Health. 2025 Jul 8:ckaf109. doi: 10.1093/eurpub/ckaf109. Epub ahead of print.
Bouwmeester TA, van der Wulp IAJ, Kusi Mensah YA, Wit FWNM, Westerhof BE, Schim van der Loeff MF, Galenkamp H, Collard D, van der Valk M, Reiss P, van den Born BH. Impaired autonomic cardiovascular control in people with HIV on long-term successful treatment. AIDS. 2025 Apr 10. doi: 10.1097/QAD.0000000000004208. Epub ahead of print.
Boyd A, Smit C, van der Eijk AA, Zaaijer H, Rijnders BJ, van Welzen B, Claassen MA, Pogány K, de Vries-Sluijs TE, de Coul EO, van der Valk M; ATHENA observational cohort. Low coverage of hepatitis D virus testing in individuals with hepatitis B virus and HIV, the Netherlands, 2000 to 2022. Euro Surveill. 2025 Feb;30(7):2400344. doi: 10.2807/1560-7917.ES.2025.30.7.2400344. PMCID: PMC11843617.
Campman SL, Boyd A, Schinkel J, Coyer L, Agyemang C, Galenkamp H, Koopman ADM, Chilunga FP, Koopsen J, Zwinderman AH, Jurriaans S, Stronks K, Prins M. SARS-CoV-2 infection and vaccination status in six ethnic groups in Amsterdam, The Netherlands, May to November 2022. Epidemiol Infect. 2025 Jan 23;153:e23. doi: 10.1017/S0950268825000056. PMCID: PMC11822580.
Campman SL, Boyd A, Schinkel J, Coyer L, Agyemang C, Galenkamp H, Koopman ADM, Chilunga FP, Koopsen J, Zwinderman AH, Jurriaans S, Stronks K, Prins M. SARS-CoV-2 infection and vaccination status in six ethnic groups in Amsterdam, The Netherlands, May to November 2022 – CORRIGENDUM. Epidemiol Infect. 2025 Mar 31;153:e53. doi: 10.1017/S0950268825000342.
Chalouni M, Van Santen DK, Berenguer J, Jarrin I, Miro JM, Klein MB, Young J, Torgersen J, Rentsch CT, Gill MJ, Epstein RL, Linas B, Zangerle R, Surial B, Rauch A, Touloumi G, Papadopoulos A, Wittkop L, Van Der Valk M, Boyd A, Monforte AD, Puoti M, Logan RW, Rein SM, Hernán MA, Lodi S. Time to direct-acting antivirals initiation and liver-related events in people with HIV and Hepatitis C virus. AIDS. 2025 Feb 19. doi: 10.1097/QAD.0000000000004161. Epub ahead of print.
Chumbe AL, van den Aardweg SMD, Boyd A, Grobben M, Koekkoek SM, Zon I, Prins M, Sliepen K, van Gils MJ, Schinkel J. Characteristics of an antibody profile associated with protection against hepatitis C virus reinfection in a high-risk cohort. Gut. 2025 Oct 23:gutjnl-2025-336302. doi: 10.1136/gutjnl-2025-336302. Epub ahead of print.
Claireaux M, Elias G, Kerster G, Kuijper LH, Duurland MC, Paul AGA, Burger JA, Poniman M, Olijhoek W, de Jong N, de Jongh R, Wynberg E, van Willigen HDG, Prins M, De Bree GJ, de Jong MD, Kuijpers TW, Eftimov F, van der Schoot CE, Rispens T, Garcia-Vallejo JJ, Ten Brinke A, van Gils MJ, van Ham SM. Deep profiling of B cells responding to various pathogens uncovers compartments in IgG memory B cell and antibody-secreting lineages. Sci Adv. 2025 Feb 21;11(8):eado1331. doi: 10.1126/sciadv.ado1331. Epub 2025 Feb 19.PMCID: PMC11837990.
Daenen K, Boyd A, Huijben JA, Stoof SCM, Bos LDJ, Gommers D, van Gorp ECM, Dalm VASH, Endeman H. Inflammatory Biomarkers Demonstrate Predictive Capacity for Mortality in COVID-19-Related ARDS Patients  Receiving High-Dose Corticosteroids: A Longitudinal Analysis. J Inflamm Res. 2025 Feb 18;18:2395-2408. doi: 10.2147/JIR.S502188. PMCID: PMC11846612.
De Bellis A, Willemsen MS, Guzzetta G, van Sighem A, Romijnders KAGJ, Reiss P, Schim van der Loeff MF, van de Wijgert JHHM, Nijhuis M, Kretzschmar MEE, Rozhnova G. Model-based evaluation of the impact of a potential HIV cure on HIV transmission dynamics. Nat Commun. 2025 Apr 22;16(1):3527. doi: 10.1038/s41467-025-58657-x.PMCID: PMC12015233.
de la Court F, Ten Hoff DOT, Prins M, Hoornenborg E, Schim van der Loeff MF, Coyer L, Boyd A. Oral pre-exposure prophylaxis retention among men who have sex with men and transgender persons: Systematic review and meta-analysis. PLoS One. 2025 Oct 17;20(10):e0333494. doi: 10.1371/journal.pone.0333494. PMCID: PMC12533894.
den Braver Nicole NR, Lakerveld J, Rutters F, Penninx BW, Generaal E, Visser M, Timmermans EJ, van der Velde JH, Rosendaal FR, de Mutsert R, Winters-van Eekelen E, Brug J, Beulens JW. Neighborhood Retail Food Environment, Diet Quality and Type 2 Diabetes Incidence in 4 Dutch Cohorts. J Nutr. 2025 Jul;155(7):2367-2375. doi: 10.1016/j.tjnut.2025.04.022. Epub 2025 Apr 30. PMCID: PMC12308082.
de Vries A, Heijne JCM, de Wit JBF, den Daas C. Investigating the influence of partner attitudes, norms and risk behavior on condom use decision-making during penile-vaginal sex with casual partners: a vignette study among dutch young people. BMC Public Health. 2025 Oct 8;25(1):3388. doi: 10.1186/s12889-025-24741-6. PMCID: PMC12505808.
de Vries A, Heijne JCM, de Wit JBF, den Daas C. Effects of behavior change techniques in interventions promoting condom use among youth in the Global North. PLoS One. 2025 Sep 23;20(9):e0328467. doi: 10.1371/journal.pone.0328467. PMCID: PMC12456814.
de Vries HJC. Lymphogranuloma venereum, an invasive and destructive sexually transmitted infection with many faces. Clin Dermatol. 2025 Sep 30:S0738-081X(25)00224-X. doi: 10.1016/j.clindermatol.2025.09.009. Epub ahead of print.
Franken DJ, Jongen VW, Rooyakkers A, Grobusch MP, Elsinga J, Boering M, Prins M, van Cleef BAGL. Adherence to stand-by emergency treatment and mosquito protection measures in short-term travellers to moderate malaria risk areas. New Microbes New Infect. 2025 Jan 1;63:101561. doi: 10.1016/j.nmni.2024.101561.; PMCID: PMC11840869.
Galenkamp H, Koopman ADM, van der Zwan JE, van den Born BH, Lok A, Moll van Charante EP, Prins M, Verhoeff AP, Zwinderman AH, Stronks K. Cohort Profile Update: The Healthy Life in an Urban Setting (HELIUS) Study. Int J Epidemiol. 2025 Apr 12;54(3):dyaf071. doi: 10.1093/ije/dyaf071. PMCID: PMC12145211.
Generaal E, Bachour Y, Klijzing S, Cornelissen A, Toering R, Hoornenborg E, Op de Coul E, Hamdiui N, Meiberg A, Siedenburg E, Prins M. Integrating hepatitis B virus, hepatitis C virus and human immunodeficiency virus screening for migrants from endemic countries into travel-related and sexual health care in Amsterdam, the Netherlands. Front Public Health. 2025 Sep 2;13:1636918. doi: 10.3389/fpubh.2025.1636918. PMCID: PMC12439341.
Hage K, Boyd A, van Santen DK, Brinkman K, Arends J, Lauw F, Rijnders B, van Eeden A, van der Valk M, Newsum A, Matser A, Schinkel J, Prins M. Hepatitis C Treatment and Behavioral Risk Among Men Who Have Sex With Men With HIV: Comparing Interferon and Direct-Acting Antiviral Eras. J Acquir Immune Defic Syndr. 2025 Jan 1;98(1):90-98. doi: 10.1097/QAI.0000000000003550.
Hage K, Boyd A, Davidovich U, Generaal E, Hoornenborg E, Zantkuijl P, van der Valk M, Verhagen D, Stalenhoef J, Hollander JD, Leyten E, Mudrikova T, Rougier H, Chiarabini T, Valantin MA, Pialoux G, Campa P, Schinkel J, Lacombe K, Prins M; ICECREAM study group. The impact of the COVID-19 and mpox outbreaks on behaviours associated with HCV infection among MSM: results from the prerandomisation phase of a clinical trial. AIDS. 2025 Oct 1;39(12):1803-1812. doi: 10.1097/QAD.0000000000004265. Epub 2025 Jun 20. PMCID: PMC12404629.
Hage K, Carson J, Hosseini-Hooshyar S, Sacks-Davis R, Stewart AC, Van Santen DK, Smit C, Van Der Valk M, Wittkop L, Klein MB, Doyle JS, Rauch A, Matthews GV, Hellard ME, Boyd A, Prins M; InCHEHC study group. Behavioural trajectories following DAA treatment for HCV among people with HIV: findings from an international consortium of prospective cohort studies. AIDS. 2025 Nov 17. doi: 10.1097/QAD.0000000000004408. Epub ahead of print.
Hage K, Hamusonde K, van Santen DK, Newsum AM, van der Valk M, Brinkman K, Arends JE, Lauw FN, Rijnders BJA, van Eeden A, Salazar-Viscaya L, Schinkel J, Boyd A, Prins M. Longitudinal trajectories of sexual behavior and incident hepatitis C reinfection among men who have sex with men with HIV. PLoS One. 2025 Jun 23;20(6):e0326094. doi: 10.1371/journal.pone.0326094.  PMCID: PMC12184900.
Hage K, Koole J, Boyd A, Matser A, Davidovich U, Bakker M, van der Hoek L, Koopsen J, Rebers S, Schinkel J, Prins M. Incidence of hepatitis C virus infection and associated determinants among men who have sex with men without HIV in Amsterdam, the Netherlands, between 2012 and 2021. Eur J Gastroenterol Hepatol. 2025 Jun 23. doi: 10.1097/MEG.0000000000003008. Epub ahead of print.
Harney BL, Sacks-Davis R, van Santen DK, Stewart AC, Matthews GV, Carson JM, Klein MB, Lacombe K, Wittkop L, Salmon D, Leleux O, Merchadou L, van der Valk M, Smit C, Prins M, Boyd A, Berenguer J, Jarrin I, Rauch A, Hellard ME, Doyle JS. Unsuccessful Direct Acting Antiviral Hepatitis C Treatment Among People With HIV: Findings From an International Cohort. Liver Int. 2025 Jan;45(1):1-13. doi: 10.1111/liv.16203. PMCID: PMC11629931.
Hertzberger R, Morselli S, Botschuijver S, Himschoot L, Steenbergen L, Bruisten S, Lewis W, Cools P, Kort R. Degradation of Resistant α-1,4-glucan by Vaginal Gardnerella Species is Associated with Bacterial Vaginosis. Curr Microbiol. 2025 Sep 2;82(10):487. doi: 10.1007/s00284-025-04459-9. PMCID: PMC12405377.
Himschoot L, Vanraepenbusch A, Selis N, Meakin P, Blumin Y, Schmid DA, Bruisten SM, Cools P. Evaluation of the diagnostic performance of four self-tests for vulvovaginal candidiasis. Sex Transm Infect. 2025 Sep 24:sextrans-2025-056642. doi: 10.1136/sextrans-2025-056642. Epub ahead of print.
Janamnuaysook R, Taesombat R, Wong J, Vannakit R, Mills S, van der Loeff MS, Reiss P, van Griensven F. Innovating healthcare: Tangerine Clinic’s role in implementing inclusive and equitable HIV care for transgender people in Thailand. J Int AIDS Soc. 2025 Jan;28(1):e26405. doi: 10.1002/jia2.26405. PMCID: PMC11666330.
Jary A, van der Zee RP, Jongen V, Ter Braak TJ, Kim Y, Meijer CJLM, van Noesel CJM, de Vries HJC, van der Loeff MFS, Steenbergen RDM. Molecular Insights Into the Natural History of Anal HSIL. J Med Virol. 2025 May;97(5):e70397. doi: 10.1002/jmv.70397. PMCID: PMC12096055.
Jongen VW, Boyd A, Albers T, Schat N, Verhagen M, van Zoest R, van den Berge M, van Nieuwkoop C, Harris VC, Bierman W, van Sighem A, van der Valk M. Harnessing registry data to identify socio-demographic and socio-economic gaps in HIV care in the Netherlands. Nat Commun. 2025 Nov 26;16(1):10517. doi: 10.1038/s41467-025-65512-6. PMCID: PMC12658163.
Jongen VW, Schim van der Loeff M, van Wees DA, van den Elshout M, Hoebe CJPA, Götz HM, de Vries H, Prins M, Hoornenborg E, Dukers-Muijrers NHTM, Boyd A. Regression-based risk scores using sociodemographic and sexual behaviour data do not predict asymptomatic sexually transmitted infections among HIV PrEP users. Sex Transm Infect. 2025 Jun 6:sextrans-2025-056506. doi: 10.1136/sextrans-2025-056506. Epub ahead of print.
Jongen VW, Wit FWNM, Boyd A, van Eeden A, Brouwer AE, Soetekouw R, El Moussaoui R, Stalenhoef J, Sigaloff KCE, Mudrikova T, Gisolf J, Burger D, Wensing AMJ, van der Valk M; ATHENA National Observational HIV Cohort. Effectiveness of bi-monthly long-acting injectable cabotegravir and rilpivirine as maintenance treatment for HIV-1 in the Netherlands: results from the Dutch ATHENA national observational cohort. Lancet HIV. 2025 Jan;12(1):e40-e50. doi: 10.1016/S2352-3018(24)00269-8.
Keuken MC, Bosdriesz JR, Boyd A, den Boogert EM, Joore IK, Dukers-Muijrers NHTM, van Rijckevorsel G, Götz HM, Goverse IE, Petrignani MWF, Raven SFH, van den Hof S, Wevers-de Boer KVC, van der Loeff MFS, Matser A. Spatio-temporal forecasting of COVID-19 cases in the Netherlands for source and contact tracing. Int J Popul Data Sci. 2025 May 7;10(1):2703. doi: 10.23889/ijpds.v10i1.2703. PMCID: PMC12058245.
Koole JCD, Bedert MRD, de la Court F, Bais I, Wit F, Stalenhoef J, Mudrikova T, Pogany K, van Benthem B, Prins M, Davidovich U, van der Valk M. Barriers and missed opportunities in PrEP uptake, use and care among men who have sex with men with recent HIV infection in the Netherlands. PLoS One. 2025 Jan 6;20(1):e0310621. doi: 10.1371/journal.pone.0310621. PMCID: PMC11703081.
Kuil S, Bavalia R, Boyd A, de Jong M, van Buul L, Schultsz C. Local antibiotic resistance surveillance in nursing homes using lot quality assurance sampling: a feasibility study. J Antimicrob Chemother. 2025 Dec 17:dkaf451. doi: 10.1093/jac/dkaf451. Epub ahead of print.
Kullberg RFJ, Appelman B, Galenkamp H, Prins M, van den Born BJ, Nieuwdorp M, Haak BW, Wiersinga WJ. Gut microbiota predicts the risk of future COVID-19 hospitalization and mortality: insights from the population-based HELIUS Study. J Infect Dis. 2025 Oct 31:jiaf541. doi: 10.1093/infdis/jiaf541. Epub ahead of print.
Kusters JMA, Schim van der Loeff MF, Heijne JCM, King AJ, de Melker HE, Heijman T, Bogaards JA, van Benthem BHB; Papillomavirus Surveillance Among STI Clinic Youngsters in the Netherlands (PASSYON) Study Group. Changes in Genital Human Papillomavirus (HPV) Prevalence During 12 Years of Girls-Only Bivalent HPV Vaccination: Results From a Biennial Repeated Cross-sectional Study. J Infect Dis. 2025 Feb 4;231(1):e165-e176. doi: 10.1093/infdis/jiae455. PMCID: PMC11793022.
Luckey A, Balasegaram M, Barbee LA, Batteiger TA, Broadhurst H, Cohen SE, Delany-Moretlwe S, de Vries HJC, Dionne JA, Gill K, Kenyon C, Kittiyaowamarn R, Lewis D, Mueller JP, Naicker V, O’Brien S, O’Donnell JP, Phanuphak N, Spooner E, Srinivasan S, Taylor SN, Unemo M, Zwane Z, Hook EW 3rd; Zoliflodacin Phase 3 Study Group. Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial. Lancet. 2025 Dec 11:S0140-6736(25)01953-1. doi: 10.1016/S0140-6736(25)01953-1. Epub ahead of print.
Mohareb AM, Ezaz G, Kim AY, Freedberg KA, Boyd A, Hyle EP. Clinical Impact of Continuation Versus Cessation of Antiviral Therapy in Chronic Hepatitis B: A Modelling Study With Implications for Hepatitis B Cure. J Viral Hepat. 2025 Oct;32(10):e70079. doi: 10.1111/jvh.70079. PMCID: PMC12444364.
Moody K, Verburgh ML, Stutterheim SE, Schim van der Loeff MF, Reiss P, Nieuwkerk PT, Geerlings SE, van der Valk M; on behalf of the AGE IV study group. Stigma-Related Disclosure Concerns and Negative Self-Image Have Not Improved Over a Decade in Older People With HIV. J Acquir Immune Defic Syndr. 2025 Nov 1;100(3):265-273. doi: 10.1097/QAI.0000000000003732.
Nieuwenburg SA, van Bijnen A, Vermey K, Stam A, Zuilhof W, Hoornenborg E, Schim van der Loeff MF, de Vries HJC. Do men who have sex with men recognise syphilis symptoms? A syphilis awareness campaign in Amsterdam, the Netherlands. Sex Transm Infect. 2025 Mar 24;101(2):118-120. doi: 10.1136/sextrans-2023-055925.
Nyaaba GN, Torensma M, Goldschmidt MI, Nørredam M, Moseholm E, Appelman B, Rostila M, Tieleman P, Biere-Rafi S, Prins M, Beune E, Agyemang C. Experiences of stigma and access to care among long COVID patients: a qualitative study in a multi-ethnic population in the Netherlands. BMJ Open. 2025 Jun 6;15(6):e094487. doi: 10.1136/bmjopen-2024-094487. PMCID: PMC12164602.
Paske KST, Brand JM, Delsing C, van den Elshout M, Hoornenborg E, Rokx C, Schippers EF, Twisk DE, Hontelez J; ATHENA observational HIV cohort. Trends and associated factors of late-stage HIV diagnosis among heterosexuals in the Netherlands between 2012-2022: An analysis of national surveillance data. Int J Infect Dis. 2025 Dec 18:108324. doi: 10.1016/j.ijid.2025.108324. Epub ahead of print.
Pepping R, Waterlander W, Groot B, Kistemaker S, Verhoeff AP, Seidell JC, Busch V. ‘Soft drinks are normal’: understanding the lived experiences of Dutch teenagers with respect to sugar-sweetened beverages: a qualitative context-mapping study. BMC Public Health. 2025 Mar 8;25(1):925. doi: 10.1186/s12889-025-22167-8.PMCID: PMC11889818.
Pospíšilová P, Fedrová P, Vrbová E, Hennelly CM, Aghakhanian F, Hawley KL, Bettin EB, Davenport TC, Bruisten SM, Zondag HCA, Grange PA, Dupin N, Arora N, Noda AA, Seña AC, Caimano MJ, Salazar JC, Juliano JJ, Moody MA, Radolf JD, Parr JB, Šmajs D. Analysis of Treponema pallidum subsp. pallidum predicted outer membrane proteins (OMPeomes) in 21 clinical samples: variant sequences are predominantly surface-exposed. mSphere. 2025 Sep 30;10(9):e0021325. doi: 10.1128/msphere.00213-25. Epub 2025 Aug 29. PMCID: PMC12482175.
Procee FA, Bosdriesz JR, Cobelens FGJ, Prins M, Hermans SM, Kunst AE. Extrapulmonary tuberculosis in The Netherlands, an epidemiologic overview, 1993-2022. J Clin Tuberc Other Mycobact Dis. 2025 Jun 26;40:100546. doi: 10.1016/j.jctube.2025.100546. PMCID: PMC12270629.
Raijmakers RPH, Lund Berven L, Keijmel SP, Rodrigo C, Wyller VBB, Katz BZ, Buchwald D, Evans RA, Gérardin P, Knoop H, Prins M, Stavem K, Stiansen-Sonerud T, Taylor R, Valencia Arroyo BM, Wensaas KA, Selvakumar JP, van den Wijngaard C, Lloyd AR, Sandler CX. Immunological associations in post-infective fatigue syndromes including Long COVID-a systematic review and meta-analysis. EBioMedicine. 2025 Oct 27;121:105970. doi: 10.1016/j.ebiom.2025.105970. Epub ahead of print.
Ramier C, Boyd A, Smit C, van Zoest R, Claassen MAA, Pogány K, Posthouwer D, de Vries-Sluijs TEMS, Carrieri P, Van der Valk M. Impact of Socio-Economic, Behavioural and Clinical Factors on Liver Disease Progression in Individuals With HIV and Hepatitis B. Liver Int. 2025 Jul;45(7):e70191. doi: 10.1111/liv.70191. PMCID: PMC12203455.
Reitsema M, Wallinga J, van Benthem BHB, Op de Coul ELM, Van Sighem A, Schim van der Loeff M, Xiridou M. Effects of improved partner notification on the transmission of HIV and N. gonorrhoea among men who have sex with men: a modelling study. Sex Transm Infect. 2025 Jan 20:sextrans-2023-055772. doi: 10.1136/sextrans-2023-055772. Epub ahead of print.  
Romijnders KAGJ, Romero Gonzalez F, Matser A, Verburgh ML, Dijkstra M, Reiss P, Kretzschmar M, Nieuwkerk P, Schim van der Loeff M, Basten M, Rozhnova G. The expected impact of a cure for HIV among people with HIV and key populations. Commun Med (Lond). 2025 May 3;5(1):152. doi: 10.1038/s43856-025-00853-3. PMCID: PMC12049444.
Rozemeijer K, Dias Gonçalves Lima F, Kuyvenhoven EJ, de Vries HJC, Steenbergen RDM, Prins JM, Siegenbeek van Heukelom ML. Swab-based anal cancer screening in men living with HIV: Projected outcomes for different screening algorithms. Int J Cancer. 2025 Dec 1;157(11):2259-2268. doi: 10.1002/ijc.70046. Epub 2025 Aug 5. PMCID: PMC12496001.
Rozemeijer K, van Veelen S, Alberts CJ, van der Loeff MS. Mortality risk in people with HIV and anal cancer. Lancet HIV. 2025 Jun;12(6):e399. doi: 10.1016/S2352-3018(25)00103-1.
Sechan F, van den Hurk AWM, Boender TS, Prins M, Matser A, Bakker M, Kootstra NA, van der Hoek L. Untreated HIV-1 infection and low CD4+ T cell counts and their effect on endemic human coronavirus (re)infection. PLOS Glob Public Health. 2025 Jun 18;5(6):e0004610. doi: 10.1371/journal.pgph.0004610. PMCID: PMC12176178.
Teker B, Schim van der Loeff MF, Boyd A, Hoornenborg E, Stam AJ, de Vries HJC, Jongen VW. Increase in Neisseria gonorrhoeae infections after ending COVID-19 lockdown measures in Amsterdam, the Netherlands. Sex Transm Infect. 2025 Apr 15;101(3):152-159. doi: 10.1136/sextrans-2024-056276.
Teker B, Hoornenborg E, Schim van der Loeff MF, Boyd A, Heijne JC, Prins M, Davidovich U, de Vries HJ, Jongen VW. Emergent informal use of doxycycline post- and pre-exposure prophylaxis among men who have sex with men and transgender and gender diverse people, the Netherlands, 2024. Euro Surveill. 2025 Jul;30(26). doi: 10.2807/1560-7917.ES.2025.30.26.2400707.
Teslya A, Heijne JCM, van der Loeff MFS, van Sighem A, Roberts JA, Dijkstra M, de Bree GJ, Schmidt AJ, Jonas KJ, Kretzschmar ME, Rozhnova G. Impact of increased diagnosis of early HIV infection and immediate antiretroviral treatment initiation on HIV transmission among men who have sex with men in the Netherlands. PLoS Comput Biol. 2025 Feb 27;21(2):e1012055. doi: 10.1371/journal.pcbi.1012055. PMCID: PMC11882050.
Tusch E, Ryom L, Pelchen-Matthews A, Mocroft A, Elbirt D, Oprea C, Günthard HF, Staehelin C, Zangerle R, Suarez I, Vehreschild JJ, Wit F, Menozzi M, d’Arminio Monforte A, Spagnuolo V, Pradier C, Carlander C, Suanzes P, Wasmuth JC, Carr A, Petoumenos K, Borgans F, Bonnet F, De Wit S, El-Sadr W, Neesgaard B, Jaschinski N, Greenberg L, Hosein SR, Gallant J, Vannappagari V, Young L, Sabin C, Lundgren J, Peters L, Reekie J; D:A:D cohort study; RESPOND cohort study. Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort Collaboration. Clin Infect Dis. 2024 Nov 22;79(5):1242-1257. doi: 10.1093/cid/ciae228.; PMCID: PMC11581700. Sonia Boender=collaborator D:A:D Cohort Study; RESPOND cohort study
Vanbellinghen MC, Boyd A, Kootstra NA, Schim van der Loeff MF, van der Valk M, Reiss P; AGEhIV Cohort study group. A Biomarker Profile Reflective of Preserved Thymic Function Is Associated With Reduced Comorbidities in Aging People With HIV: An AGEhIV Cohort Analysis. J Infect Dis. 2025 Mar 17;231(3):622-632. doi: 10.1093/infdis/jiae603.
van Bergen IJW, Heijne JCM, de Bruin M, van Wees DA. Impact of reduced chlamydia testing on STI testing and provider preferences in the Netherlands: an experimental vignette study. Sex Transm Infect. 2025 Dec 11:sextrans-2025-056703. doi: 10.1136/sextrans-2025-056703. Epub ahead of print.
van der Wulp IAJ, Wit FW, Jongen VW, Brinkman K, Prins JM, Richel O, Schippers EF, van Twillert G, Reiss P, van der Valk M. Earlier initiation of treatment following HIV acquisition reduces non-AIDS-defining malignancy risk. Clin Infect Dis. 2025 Nov 5:ciaf595. doi: 10.1093/cid/ciaf595. Epub ahead of print.
van Enter BJD, de Zeeuw J, Bakar O, Bakhlakh S, Schim van Der Loeff MF, Boersma C, Edelstein M, Vervoort JPM, Jansen DEMC. Health system barriers to HPV-vaccination in adolescent females with a Moroccan or Turkish migration background in the Netherlands: A qualitative study. Vaccine. 2025 Mar 19;50:126827. doi: 10.1016/j.vaccine.2025.126827. Epub 2025 Feb 4.
van Paassen PM, Boyd AC, Pasternak AO, Maurer I, Harskamp AM, Grijsen ML, Jurriaans S, Prins JM, Kootstra NA, de Bree GJ. Soluble CD14 and IL-12p70 on early ART predict HIV load setpoint after treatment interruption. AIDS. 2025 Feb 14. doi: 10.1097/QAD.0000000000004159. Epub ahead of print.
van Veelen S, Alberts C, Hoornenborg E, Bruisten SM, Vermeij K, van der Klis F, Noordpool L, Bogaards JA, Schim van der Loeff MF. Human papillomavirus (HPV) vaccine effectiveness against anal HPV-16 and HPV-18 infections among young men who have sex with men visiting the sexual health center of Amsterdam (HPV4M): study protocol of an observational study. BMJ Open. 2025 Aug 26;15(8):e101634. doi: 10.1136/bmjopen-2025-101634. PMCID: PMC12410653.
Verveen A, Verfaillie SCJ, Visser D, Koch DW, Verwijk E, Geurtsen GJ, Roor J, Appelman B, Boellaard R, van Heugten CM, Horn J, Hulst HE, de Jong MD, Kuut TA, van der Maaden T, van Os YMG, Prins M, Visser-Meily JMA, van Vugt M, van den Wijngaard CC, Nieuwkerk PT, van Berckel B, Tolboom N, Knoop H. Neuropsychological functioning after COVID-19: Minor differences between individuals with and without persistent complaints after SARS-CoV-2 infection. Clin Neuropsychol. 2025 Feb;39(2):347-362. doi: 10.1080/13854046.2024.2379508. Epub 2024 Jul 17.PMCID: PMC11875436.
Vink M, Ahmad M, Sabawoon MF, Nahzat MS, Siddiqi AM, Naseem M, Alizoi N, Schallig HD, Bradley J, Moore S, Schim van der Loeff MF. Do long-lasting insecticidal nets retain their efficacy after three years of usage in Afghanistan? Findings from a study on survivorship, physical integrity, insecticidal activity and wash resistance. Malar J. 2025 Apr 15;24(1):121. doi: 10.1186/s12936-025-05346-1. PMCID: PMC12001384.
Visser D, Golla SSV, Palard-Novello X, Verfaillie SCJ, Verveen A, Koch DW, Rikken RM, van de Giessen E, Nieuwkerk PT, den Hollander ME, Horn J, van Heugten CM, de Jong MD, van den Wijngaard CC, van der Maaden T, van Os YMG, Prins M, Visser-Meily JMA, Schober P, Schuit RC, Kassiou M, Windhorst AD, Biere-Rafi S, Appelman B, van Vugt M, Barkhof F, van Berckel BNM, Boellaard R, Knoop H, Tolboom N. Varying Levels of Inflammatory Activity in Brain and Body of Patients with Persistent Fatigue and Difficulty Concentrating After COVID-19: A TSPO PET Study. J Nucl Med. 2025 Nov 3;66(11):1787-1794. doi: 10.2967/jnumed.124.269297. PMCID: PMC12582180.
Wehrli S, Hartner AM, Boender TS, Arnrich B, Irrgang C. Information Pathways and Voids in Critical German Online Communities During the COVID-19 Vaccination Discourse: Cross-Platform and Mixed Methods Analysis. J Med Internet Res. 2025 Oct 17;27:e76309. doi: 10.2196/76309. PMCID: PMC12557652.
Werner L, Jongen VW, Bruisten SM, Schim van der Loeff MF, Hoornenborg E, de Vries HJC, Heijne JCM. Estimated effect of reduced asymptomatic testing on missed Chlamydia trachomatis detections among women and heterosexual men in the Netherlands: a retrospective observational study. Lancet Reg Health Eur. 2025 Oct 6;58:101468. doi: 10.1016/j.lanepe.2025.101468. PMCID: PMC12537342.
Wijstma ES, Jongen VW, Boyd A, De Vries HJC, F Schim Van Der Loeff M, Prins M, Hoornenborg E. Subpopulations with frequent healthcare barriers have increased risk of sexually transmitted infections and dropping out from HIV pre-exposure prophylaxis care. AIDS. 2025 Jul 2. doi: 10.1097/QAD.0000000000004224. Epub ahead of print.

Selectie artikelen uit 2024

Alexiou ZW, Hoenderboom BM, Hoebe CJPA, Dukers-Muijrers NHTM, Götz HM, van der Sande MAB, de Vries HJC, den Hartog JE, Morré SA, van Benthem BHB. Reproductive tract complication risks following Chlamydia trachomatis infections: a long-term prospective cohort study from 2008 to 2022. Lancet Reg Health Eur. 2024 Aug 17;45:101027. doi: 10.1016/j.lanepe.2024.101027.  PMCID: PMC11378087.
Alexiou ZW, Hoenderboom BM, Hoebe CJPA, Dukers-Muijrers NHTM, Götz HM, van der Sande MAB, de Vries HJC, den Hartog JE, Morré SA, van Benthem BHB. The importance of understanding pelvic inflammatory disease as a polymicrobial infection – authors’ reply. Lancet Reg Health Eur. 2024 Oct 30;47:101116. doi: 10.1016/j.lanepe.2024.101116. PMCID: PMC11554624.
Begré L, Boyd A, Salazar-Vizcaya L, Suter-Riniker F, Béguelin C, Rockstroh JK, Günthard HF, Calmy A, Cavassini M, Stöckle M, Schmid P, Bernasconi E, Levrero M, Zoulim F, Wandeler G, Rauch A; Swiss HIV Cohort Study (SHCS). Long-term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir-containing antiretroviral therapy. HIV Med. 2024 Feb;25(2):291-298. doi: 10.1111/hiv.13561. Epub 2023 Oct 10.  
Begré L, Boyd A, Plissonnier ML, Testoni B, Salazar-Vizcaya L, Suter-Riniker F, Scholtès C, Béguelin C, Rockstroh JK, Günthard HF, Calmy A, Cavassini M, Hirsch HH, Schmid P, Bernasconi E, Levrero M, Wandeler G, Zoulim F, Rauch A; Swiss HIV Cohort Study. Circulating HBV RNA and hepatitis B core-related antigen trajectories in persons with HIV/HBV coinfection and HBsAg loss on tenofovir therapy. J Infect Dis. 2024 Apr 16:jiae189. doi: 10.1093/infdis/jiae189. Epub ahead of print.
Bermejo-Jambrina M, van der Donk LE, van Hamme JL, Wilflingseder D, de Bree G, Prins M, de Jong M, Nieuwkerk P, van Gils MJ, Kootstra NA, Geijtenbeek TB. Control of complement-induced inflammatory responses to SARS-CoV-2 infection by anti-SARS-CoV-2 antibodies. EMBO J. 2024 Feb 28. doi: 10.1038/s44318-024-00061-0. Epub ahead of print.
Bolijn R, Spijkerman AMW, Galenkamp H, Blokstra A, Coyer L, Boyd A, Prins M, Stronks K. Differences in SARS-CoV-2 antibody prevalence at the end of the pre-vaccination period between age groups: A cross-sectional analysis of the multi-ethnic population-based HELIUS study. PLoS One. 2024 Oct 8;19(10):e0311196. doi: 10.1371/journal.pone.0311196. PMCID: PMC11460694.
Boyd A, Mathieu P, Françoise U, Rougier H, Chiarabini T, Valin N, Lacombe K, Woerther PL, Surgers L. Sexual behaviors and risk of extended-spectrum β-lactamase-producing Enterobacterales carriage: A cross-sectional analysis. Int J Infect Dis. 2024 Dec;149:107277. doi: 10.1016/j.ijid.2024.107277. Epub 2024 Oct 23.
Busch V, Steenkamer I, van Nassau F, van Opdorp P, van Houtum L, Verhoeff A, Twisk J. The Effects of the Jump-In Whole-School Intervention on the Weight Development of Children in Amsterdam, the Netherlands. J Sch Health. 2024 Jan;94(1):37-46. doi: 10.1111/josh.13363. Epub 2023 Jul 30.
Carrico AW, Ewart LD, Davidovich U, Maher L, Jonas KJ, Horvath KJ, Hirshfield S, Guadamuz TE, Carney T, Grov C. Responding to the global epidemic of amphetamine-type stimulant use compromising biomedical HIV prevention among men who have sex with men. Lancet HIV. 2024 Jun;11(6):e350-e352. doi: 10.1016/S2352-3018(24)00086-9.
Cespedes MS, Das M, Yager J, Prins M, Krznaric I, de Jong J, Xiao D, Shao Y, Wong P, Kintu A, Carter C, Hoornenborg E, Ruane P, Phoenix J, Younis I, Halperin J. Gender Affirming Hormones Do Not Affect the Exposure and Efficacy of F/TDF or F/TAF for HIV Preexposure Prophylaxis: A Subgroup Analysis from the DISCOVER Trial. Transgend Health. 2024 Jan 31;9(1):46-52. doi: 10.1089/trgh.2022.0048. PMCID: PMC10835152.
Concincion S, van Houtum L, van de Vorst B, Verhoeff A, Dedding C. Obesity care for youth during the COVID-19 pandemic: Challenges youth healthcare nurses experienced in providing obesity care in the Netherlands. Nurs Health Sci. 2024 Mar;26(1):e13084. doi: 10.1111/nhs.13084.
Concincion S, van Houtum L, Verhoeff A, Dedding C. Bored, afraid, alone: What can we learn from children with paediatric obesity about the impact of the COVID-19 pandemic for future pandemics, care practices and policies? J Pediatr Nurs. 2024 Mar 23;77:162-171. doi: 10.1016/j.pedn.2024.03.025. Epub ahead of print.
Concincion S, Dedding C, Verhoeff A, van Houtum L. Building space for children’s voices: The added value of participatory and creative approaches for child-centred integrated obesity care. J Pediatr Nurs. 2024 Nov-Dec;79:e223-e231. doi: 10.1016/j.pedn.2024.10.025. Epub 2024 Oct 28. PMID: 39490280.
de Jong SPJ, Felix Garza ZC, Gibson JC, van Leeuwen S, de Vries RP, Boons GJ, van Hoesel M, de Haan K, van Groeningen LE, Hulme KD, van Willigen HDG, Wynberg E, de Bree GJ, Matser A, Bakker M, van der Hoek L, Prins M, Kootstra NA, Eggink D, Nichols BE, Han AX, de Jong MD, Russell CA. Determinants of epidemic size and the impacts of lulls in seasonal influenza virus circulation. Nat Commun. 2024 Jan 18;15(1):591. doi: 10.1038/s41467-023-44668-z. PMCID: PMC10796432.
den Boogert EM, van Aar F, Heijne JCM. Investigating possibilities for surveillance of long term chlamydia complications in the Netherlands: A qualitative study. PLoS One. 2024 Jun 11;19(6):e0305279. doi: 10.1371/journal.pone.0305279. PMCID: PMC11166304.
de Oliveira Bressane Lima P, van de Kassteele J, Schipper M, Smorenburg N, S van Rooijen M, Heijne J, D van Gaalen R. Automating COVID-19 epidemiological situation reports based on multiple data sources, the Netherlands, 2020 to 2023. Comput Methods Programs Biomed. 2024 Sep 20;257:108436. doi: 10.1016/j.cmpb.2024.108436. Epub ahead of print.
Dias Gonçalves Lima F, Rozemeijer K, van der Zee RP, Dick S, Ter Braak TJ, Geijsen DE, Meijnen P, Lissenberg-Witte BI, van Noesel CJM, de Vries HJC, Prins JM, Steenbergen RDM. DNA methylation analysis on anal swabs for anal cancer screening in people living with HIV. J Infect Dis. 2024 Dec 24:jiae627. doi: 10.1093/infdis/jiae627. Epub ahead of print.
Drouin N, Elfrink HL, Boers SA, van Hugten S, Wessels E, de Vries JJC, Groeneveld GH, Miggiels P, Van Puyvelde B, Dhaenens M, Budding AE, Ran L, Masius R, Takats Z, Boogaerds A, Bulters M, Muurlink W, Oostvogel P, Harms AC, van der Lubben M, Hankemeier T. A Targeted LC-MRM3 Proteomic Approach for the Diagnosis of SARS-CoV-2 Infection in Nasopharyngeal Swabs. Mol Cell Proteomics. 2024 Jul;23(7):100805. doi: 10.1016/j.mcpro.2024.100805. Epub 2024 Jun 17. PMCID: PMC11284538.
Hage K, Boyd A, Op de Coul ELM, Sarink D, Hoornenborg E, Prins M. Hepatitis C virus infection is uncommon at baseline and during follow-up among individuals using PrEP in the Dutch national PrEP programme between 2019 and 2022. Sex Transm Infect. 2024 Jun 24:sextrans-2024-056169. doi: 10.1136/sextrans-2024-056169. Epub ahead of print.
Harney BL, Sacks-Davis R, van Santen DK, Traeger MW, Wilkinson AL, Asselin J, Fairley CK, Roth N, Bloch M, Matthews GV, Donovan B, Guy R, Stoové M, Hellard ME, Doyle JS. Hepatitis C virus reinfection incidence among gay and bisexual men with HIV in Australia from 2016 to 2020. Liver Int. 2024 Jan 31. doi: 10.1111/liv.15841. Epub ahead of print.
Harney BL, Sacks-Davis R, Agius P, van Santen DK, Traeger MW, Wilkinson AL, Asselin J, Fairley CK, Roth N, Bloch M, Matthews GV, Donovan B, Guy R, Stoové M, Hellard ME, Doyle JS. Risk of Primary Incident Hepatitis C Infection Following Bacterial Sexually Transmissible Infections Among Gay and Bisexual Men in Australia From 2016 to 2020. Open Forum Infect Dis. 2024 Feb 19;11(4):ofae099. doi: 10.1093/ofid/ofae099; PMCID: PMC10977630.
Haverkate MR, Willemstein IJ, van Ewijk CE, Adam PC, Lanooij SJ, Jonker-Jorna P, van Bokhoven C, van Rijckevorsel GG, Hoornenborg E, David S, Mollema L, Te Wierik MJ, Lange J, Franz E, de Melker HE, Op de Coul EL, Hahné SJ. Factors potentially contributing to the decline of the mpox outbreak in the Netherlands, 2022 and 2023. Euro Surveill. 2024 May;29(21):2300608. doi: 10.2807/1560-7917.ES.2024.29.21.2300608. PMCID: PMC11128738.
de Jong M, van der Loeff MFS, Schilperoort R, Vennema H, van der Weijden C, Langeveld J, Welkers M, Prins M, de Roda Husman AM, Fanoy E, Medema G. Use of passive samplers as sewage surveillance tool to monitor a hepatitis A outbreak at a school in Amsterdam, the Netherlands, Oct 2022 – March 2023. BMC Infect Dis. 2024 Sep 27;24(1):1044. doi: 10.1186/s12879-024-09938-1. PMCID: PMC11430438.
Jongen VW, van Dongen N, Sohn AH. Human papillomavirus infection among adolescents living with HIV: a focus on prevention. Curr Opin HIV AIDS. 2024 Jun 20. doi: 10.1097/COH.0000000000000868. Epub ahead of print.
Jongen VW, Daans C, van Sighem A, Schim van der Loeff M, Hage K, Welling C, von Vaupel-Klein A, den Heijer M, Peters EJG, van der Valk M, Reiss P, Prins M, Hoornenborg E; ATHENA observational HIV cohort. Assessing the HIV care continuum among transgender women during 11 years of follow-up: results from the Netherlands’ ATHENA observational cohort. J Int AIDS Soc. 2024 Aug;27(8):e26317. doi: 10.1002/jia2.26317. PMCID: PMC11310271.
Kerkhof MPJ, Lefevre ER, de Mast Q. Een nieuw denguevaccin voor reizigers. TIJDSCHR INFECT 2024;19(2):61–5
Kolodziej LM, Paap KC, van Buul LW, Kuil SD, Hertogh CMPM, de Jong MD. Influence of the COVID-19 Pandemic on Influenza and SARS-CoV-2 Vaccination Willingness Among Dutch Nursing Home Health Care Workers. J Am Med Dir Assoc. 2024 Dec 27;26(2):105420. doi: 10.1016/j.jamda.2024.105420. Epub ahead of print.
Kullberg RFJ, Wikki I, Haak BW, Kauko A, Galenkamp H, Peters-Sengers H, Butler JM, Havulinna AS, Palmu J, McDonald D, Benchraka C, Abdel-Aziz MI, Prins M, Maitland van der Zee AH, van den Born BJ, Jousilahti P, de Vos WM, Salomaa V, Knight R, Lahti L, Nieuwdorp M, Niiranen T, Wiersinga WJ. Association between butyrate-producing gut bacteria and the risk of infectious disease hospitalisation: results from two observational, population-based microbiome studies. Lancet Microbe. 2024 Sep;5(9):100864. doi: 10.1016/S2666-5247(24)00079-X. Epub 2024 Jun 20.
Kusters JMA, Obels I, van der Klis FRM, King AJ, Heijman T, Heijne JCM, van Benthem BHB; PASSYON study group; van der Loeff MFS. Prevalence and risk factors for HPV seropositivity and anogenital DNA positivity among men who have sex with men: a repeated cross-sectional study. Int J Infect Dis. 2024 May 20;145:107094. doi: 10.1016/j.ijid.2024.107094. Epub ahead of print.
Kusters JMA, Schim van der Loeff MF, Heijne JCM, King AJ, de Melker HE, Heijman T, Bogaards JA, van Benthem BHB. Changes in Genital HPV Prevalence during 12 Years Girls-Only Bivalent HPV Vaccination: Results from a Biennial Repeated Cross-Sectional Study. J Infect Dis. 2024 Sep 13:jiae455. doi: 10.1093/infdis/jiae455. Epub ahead of print.
Kusters JMA, van der Loeff MFS, van Benthem BHB, King AJ; PASSYON study group; de Melker HE, Heijman T, Heijne JCM. Effectiveness of bivalent HPV vaccination against genital HPV DNA-positivity of a catch-up campaign at age 13-16 years compared to routine vaccination at age 12 years: a biennial repeated cross-sectional study. BMC Med. 2024 Oct 15;22(1):469. doi: 10.1186/s12916-024-03686-4. PMCID: PMC11475922.
Landovitz RJ, Tao L, Yang J, de Boer M, Carter C, Das M, Baeten JM, Liu A, Hoover KW, Celum C, Grinsztejn B, Morris S, Wheeler DP, Mayer KH, Golub SA, Bekker LG, Diabaté S, Hoornenborg E, Myers J, Leech AA, McCormack S, Chan PA, Sweat M, Matthews LT, Grant R; Global F/TDF PrEP Study Team. HIV-1 Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-Exposure Prophylaxis: Pooled Analysis From 72 Global Studies. Clin Infect Dis. 2024 Mar 14:ciae143. doi: 10.1093/cid/ciae143. Epub ahead of print.
Loef B, Boer JMA, Beekman M, Campman SL, Hoogendijk EO, Huider F, Pagen DME, Splinter MJ, van der Velde JHPM, Boomsma DI, Dagnelie PC, van Dongen J, de Geus EJC, Huisman M, Ikram MA, Koster A, Licher S, Mierau JO, de Mutsert R, Picavet HSJ, Rosendaal FR, Schram MT, Slagboom PE, van der Spoel E, Stronks K, Verschuren WMM, van den Berg SW; Lifelines Corona Research initiative. The association of overweight, obesity, and long-term obesity with SARS-CoV-2 infection: a meta-analysis of 9 population-based cohorts from the Netherlands Cohorts Consortium. Int J Obes (Lond). 2024 Oct 31. doi: 10.1038/s41366-024-01660-x. Epub ahead of print.
McGuinness SL, Veit O, Angelin M, Antonini P, Boecken G, Boering M, Bühler S, Calleri G, Éperon G, Flaherty G, Gossner C, Askling HH, Holmberg V, Kuenzli E, Landry P, Lefevre E, Libman M, Longley N, Maniewski-Kelner U, Neumayr A, Rapp C, Ridpath AD, Rodriguez N, Rosdahl A, Rosenbusch D, Rossanese A, Rothe C, Schlagenhauf P, Soentjens P, Staehelin C, Visser J, Visser L, Wagner A, Walker A, Wiedermann U, Wroczynska A, Hatz C. Streamlining malaria prevention recommendations for travellers: current and future approaches. J Travel Med. 2024 Aug 21:taae113. doi: 10.1093/jtm/taae113. Epub ahead of print.
Meyer L, Schim van der Loeff MF. Sexually transmitted infections in the preexposure prophylaxis era. AIDS. 2024 Jun 1;38(7):1085-1086. doi: 10.1097/QAD.0000000000003872. Epub 2024 May 1.
Miura F, Backer JA, van Rijckevorsel G, Bavalia R, Raven S, Petrignani M, Ainslie KEC, Wallinga J; Dutch Mpox Response Team. Time Scales of Human Mpox Transmission in The Netherlands.. J Infect Dis. 2024 Mar 14;229(3):800-804. doi: 10.1093/infdis/jiad091.  PMCID: PMC10938196.
Mohareb AM, Kim AY, Boyd A, Noubary F, Kouamé MG, Anglaret X, Coffie PA, Eholie SP, Freedberg KA, Hyle EP. Virological, serological and clinical outcomes in chronic hepatitis B virus infection: development and validation of the HEPA-B simulation model. BMJ Open. 2024 Jan 12;14(1):e073498. doi: 10.1136/bmjopen-2023-073498. PMCID: PMC10806737.
Mohareb AM, Kouamé MG, Nouaman M, Kim AY, Larmarange J, Neilan AM, Lacombe K, Freedberg KA, Boyd A, Coffie P, Hyle EP. What does the scale-up of long-acting HIV pre-exposure prophylaxis mean for the global hepatitis B epidemic? J Int AIDS Soc. 2024 Mar;27(3):e26218. doi: 10.1002/jia2.26218. PMCID: PMC10935702.
Nieuwenburg SA, Jongen VW, Schim van der Loeff M, de Vries H, van Dam A. Seroconversion in syphilis screening without positive confirmatory tests points at early infection. Sex Transm Infect. 2024 Jan 22:sextrans-2023-055973. doi: 10.1136/sextrans-2023-055973.
Nieuwenburg SA, Bruisten SM, Heijman T, Vermeulen W, van Dam AP, Schim van der Loeff MF, de Vries HJC. Use of home-based self-collected dried blood spots to test for syphilis, HIV, hepatitis C and B virus infections and measuring creatinine concentration. Sex Transm Dis. 2024 Mar 2. doi: 10.1097/OLQ.0000000000001941. Epub ahead of print.
Nieuwenburg SA, van Bijnen A, Vermey K, Stam A, Zuilhof W, Hoornenborg E, Schim van der Loeff MF, de Vries HJC. Do men who have sex with men recognise syphilis symptoms? A syphilis awareness campaign in Amsterdam, the Netherlands. Sex Transm Infect. 2024 Jul 25:sextrans-2023-055925. doi: 10.1136/sextrans-2023-055925. Epub ahead of print.
Pantazis N, Sabin CA, Grabar S, Van der Valk M, Jarrin I, van Sighem A, Meyer L, Carlander C, Gill J, Volny Anne A, Spire B, Tariq S, Burns F, Costagliola D, Ruiz-Burga E, Touloumi G, Porter K; CASCADE Collaboration [Davidovich Udi]. Changes in bodyweight after initiating antiretroviral therapy close to HIV-1 seroconversion: an international cohort collaboration. Lancet HIV. 2024 Oct;11(10):e660-e669. doi: 10.1016/S2352-3018(24)00183-8. Epub 2024 Aug 23. PMID: 39186940.
Reitsema M, Wallinga J, van Sighem AI, Bezemer D, van der Valk M, van Aar F, Maria Heijne JC, Hoornenborg E, Rozhnova G, van Benthem B, Xiridou M. Impact of varying pre-exposure prophylaxis programs on HIV and Neisseria gonorrhoeae transmission among MSM in the Netherlands: a modelling study. J Acquir Immune Defic Syndr. 2024 Aug 22. doi: 10.1097/QAI.0000000000003511. Epub ahead of print.
Requena MB, Protopopescu C, Stewart AC, van Santen DK, Klein MB, Jarrin I, Berenguer J, Wittkop L, Salmon D, Rauch A, Prins M, van der Valk M, Sacks-Davis R, Hellard ME, Carrieri P, Lacombe K; InCHEHC Collaboration. All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019. Int J Drug Policy. 2024 Jan 6;124:104311. doi: 10.1016/j.drugpo.2023.104311. Epub ahead of print.
Rotsaert A, Smekens T, Jaminé D, Di Zinno T, Deblonde J, Lambert ML, Florence E, Reyniers T, Vanhamel J, Lucet C, van der Loeff MS, Hensen B, Vuylsteke B. Pre-exposure prophylaxis (PrEP) use trajectories and incidence of HIV and other sexually transmitted infections among PrEP users in Belgium: a cohort analysis of insurance claims data from 2017 to 2019. BMC Public Health. 2024 Aug 23;24(1):2296. doi: 10.1186/s12889-024-19691-4. PMCID: PMC11342504.
Rozemeijer K, Dias Gonçalves Lima F, Ter Braak TJ, Hesselink AT, Prins JM, de Vries HJC, Steenbergen RDM. Analytical validation and diagnostic performance of the ASCL1/ZNF582 methylation test for detection of high-grade anal intraepithelial neoplasia and anal cancer. Tumour Virus Res. 2024 Jun;17:200275. doi: 10.1016/j.tvr.2023.200275. Epub 2023 Dec 30. PMCID: PMC10821616.
Sacks-Davis R, van Santen DK, Boyd A, Young J, Stewart A, Doyle JS, Rauch A, Mugglin C, Klein M, van der Valk M, Smit C, Jarrin I, Berenguer J, Lacombe K, Requena MB, Wittkop L, Leleux O, Bonnet F, Salmon D, Matthews GV, Guy R, Martin NK, Spelman T, Prins M, Stoove M, Hellard M; InCHEHC Collaboration. Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies. Lancet HIV. 2024 Feb;11(2):e106-e116. doi: 10.1016/S2352-3018(23)00267-9. Epub 2024 Jan 12.
Schönnesson LN, Cluver L, Eriksson LE, Davidovich U, Harding R, Spire B, Catalan J, Karkouri M, Steventon-Roberts K, Prince B, Sherr L. The power for action – now! AIDS Care. 2024 May 9:1-5. doi: 10.1080/09540121.2024.2321697. Epub ahead of print.
Schuele L, Boter M, Nieuwenhuijse DF, Götz H, Fanoy E, de Vries H, Vieyra B, Bavalia R, Hoornenborg E, Molenkamp R, Jonges M, van den Ouden A, Simões M, van den Lubben M, Koopmans M, Welkers MRA, Oude Munnink BB. Circulation, viral diversity and genomic rearrangement in mpox virus in the Netherlands during the 2022 outbreak and beyond. J Med Virol. 2024 Jan;96(1):e29397. doi: 10.1002/jmv.29397.
Sechan F, Edridge AWD, van Rijswijk J, Jebbink MF, Deijs M, Bakker M, Matser A, Prins M, van der Hoek L. Influenza-like illness symptoms due to endemic human coronavirus reinfections are not influenced by the length of the interval separating reinfections. Microbiol Spectr. 2024 Feb 8:e0391223. doi: 10.1128/spectrum.03912-23. Epub ahead of print.
Shamier MC, Zaeck LM, Götz HM, Vieyra B, Verstrepen BE, Wijnans K, Welkers MR, Hoornenborg E, van Cleef BA, van Royen ME, Jonas KJ, Koopmans MP, de Vries RD, van de Vijver DA, GeurtsvanKessel CH. Scenarios of future mpox outbreaks among men who have sex with men: a modelling study based on cross-sectional seroprevalence data from the Netherlands, 2022. Euro Surveill. 2024 Apr;29(17):2300532. doi: 10.2807/1560-7917.ES.2024.29.17.2300532. PMCID: PMC11063670.
Sluimer J, van den Akker WMR, Goderski G, Swart A, van der Veer B, Cremer J, Chung NH, Molenkamp R, Voermans J, Guldemeester J; Working Group SARS-CoV-2 Diagnostics The Netherlands; Eggink D, Presser LD, Meijer A. High quality of SARS-CoV-2 molecular diagnostics in a diverse laboratory landscape through supported benchmark testing and External Quality Assessment. Sci Rep. 2024 Jan 16;14(1):1378. doi: 10.1038/s41598-023-50912-9. PMCID: PMC10792020.
Teker B, Schim van der Loeff M, Hoornenborg E, Boyd A, Reedijk S, van Dam A, Jongen VW, de Vries H. Minimum inhibitory concentrations of Neisseria gonorrhoeae strains in clients of the Amsterdam sexual health clinic with a Dutch versus an international sexual network. Sex Transm Infect. 2024 Apr 18;100(3):173-180. doi: 10.1136/sextrans-2023-055988.
Stam AJ, Buchholtz NVEJ, Bierman WFW, van Crevel R, Hoepelman AIM, Claassen MAA, Ammerlaan HSM, van Welzen BJ, van Kasteren MEE, van Lelyveld SFL, de Jong D, Tesselaar K, van Luin M, Nijhuis M, Wensing AMJ, Lowerit Study Team. Dynamics of Low-Level Viremia and Immune Activation after Switching to a Darunavir-Based Regimen. Viruses. 2024 Jan 25;16(2):182. doi: 10.3390/v16020182. PMCID: PMC10893305.
Stam AJ, Groenewegen H, Vissink A, Wensing AMJ, Nijhuis M, Bierman WFW. Periodontal inflammation as a potential driver of HIV low level viremia. PLoS One. 2024 Jun 17;19(6):e0305641. doi: 10.1371/journal.pone.0305641. PMCID: PMC11182545.
Teijema MT, van der Meij LLM, de Groot SM, Hoogerbrugge A, Hoornenborg E. Towards zero new HIV infections in Amsterdam in 2026; building bridges between community organizations, undocumented migrants and sexual healthcare providers. Sex Transm Dis. 2024 Jul 18. doi: 10.1097/OLQ.0000000000002041. Epub ahead of print.
Teker B, Schim van der Loeff MF, Boyd A, Hoornenborg E, Stam AJ, de Vries HJC, Jongen VW. Increase in Neisseria gonorrhoeae infections after ending COVID-19 lockdown measures in Amsterdam, the Netherlands. Sex Transm Infect. 2024 Dec 6:sextrans-2024-056276. doi: 10.1136/sextrans-2024-056276. Epub ahead of print.
Vanbellinghen MC, Boyd A, Kootstra NA, Schim van der Loeff MF, van der Valk M, Reiss P; AGEhIV Cohort study group: Scientific oversight and coordination; Data management; Statistical support; Central laboratory support; Project management and administrative support; Participating HIV physicians and nurses:; Other collaborators:. A biomarker profile reflective of preserved thymic function is associated with reduced comorbidities in ageing people with HIV: an AGEhIV Cohort analysis. J Infect Dis. 2024 Dec 10:jiae603. doi: 10.1093/infdis/jiae603. Epub ahead of print.
van de Kerkhof MPJ, Lefevre ER, de Mast Q. A new dengue vaccine for travelers. TVI (Tijdschrift voor Infectieziekten); Jaargang 19; mei 2024
van den Elshout MAM, Wijstma ES, Boyd A, Jongen VW, Coyer L, Anderson PL, Davidovich U, de Vries HJC, Prins M, Schim van der Loeff MF, Hoornenborg E; Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam Initiative (H-TEAM). Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort. PLoS Med. 2024 May 8;21(5):e1004328. doi: 10.1371/journal.pmed.1004328. PMCID: PMC11111007.
Van den End Sanne, van Ewijk Katja, Keur Ingrid, Boreel Jaap, van Cleef Brigitte, Eblé Phaedra, van Rijckevorstel Gini, te Wierik Margreet Gedeeld eerste auteurschap; correspondentie naar s.vandenend@nvwa.nl TIJDSCHRIFT VOOR DIERGENEESKUNDE Jaargang 149, aflevering 9, september 2024 https://www.knmvd.nl/rabies-in-nederland-twee-casussen-met-veterinaire-en-humane-dilemmas/ zie ook als bijlage U schijf Publicaties, 2024, artikelen
van der Zalm MM, Jongen VW, Swanepoel R, Zimri K, Allwood B, Palmer M, Dunbar R, Goussard P, Schaaf HS, Hesseling AC, Seddon JA. Impaired lung function in adolescents with pulmonary tuberculosis during treatment and following treatment completion. EClinicalMedicine. 2024 Jan 3;67:102406. doi: 10.1016/j.eclinm.2023.102406. PMCID: PMC10796966.
van Dijk M, Boyd A, Brakenhoff SM, Isfordink CJ, van Zoest RA, Verhagen MD, de Knegt RJ, Drenth JPH, van der Valk M; HepNed study group. Socio-economic factors associated with loss to follow-up among individuals with HCV: A Dutch nationwide cross-sectional study. Liver Int. 2024 Jan;44(1):52-60. doi: 10.1111/liv.15729. Epub 2023 Sep 17.
van der Loo CHM, Schim van der Loeff R, Martín A, Gomez-Sal P, Borst MLG, Pouwer K, Minnaard AJ. Correction: π-Facial selectivity in the Diels-Alder reaction of glucosamine-based chiral furans and maleimides. Org Biomol Chem. 2024 Jan 3;22(2):395-397. doi: 10.1039/d3ob90168h. Erratum for: Org Biomol Chem. 2023 Mar 1;21(9):1888-1894.
van Santen DK, Stewart A, Doyle JS, Stoové MA, Asselin J, Klein MB, Young J, Berenguer J, Jarrin I, Lacombe K, Wittkop L, Leleux O, Salmon D, Bonnet F, Rauch A, Mugglin C, Matthews G, Prins M, Smit C, Boyd A, van der Valk M, Sacks-Davis R, Hellard ME; InCHEHC Study Group. Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC). Int J Epidemiol. 2024 Feb 1;53(1):dyad154. doi: 10.1093/ije/dyad154.; PMCID: PMC10859136.
van Wees D, Coyer L, van den Elshout M, de Coul EO, van Aar F. The Best Predictor of Future Behavior May Be the Past: Exploring Behavior Change in Men Who Have Sex with Men Using Pre-exposure Prophylaxis in the Netherlands. Arch Sex Behav. 2024 May 6. doi: 10.1007/s10508-024-02863-z. Epub ahead of print.
Veit O, Maniewski U, Rothe C, Eperon G, Boering M, Alcedo S, Boecken G, Ramharter M, Schel N, Soentjens P, Staehelin C, van Vugt M, Weitzel T, Visser LG, Schlagenhauf P, Hatz C, Neumayr A; malaria working groups (listed at the end). Methodology of the joint malaria prevention recommendations of Switzerland, Germany, Belgium, and the Netherlands. J Travel Med. 2024 Sep 26:taae129. doi: 10.1093/jtm/taae129. Epub ahead of print.
Verveen A, Verfaillie SCJ, Visser D, Koch DW, Verwijk E, Geurtsen GJ, Roor J, Appelman B, Boellaard R, van Heugten CM, Horn J, Hulst HE, de Jong MD, Kuut TA, van der Maaden T, van Os YMG, Prins M, Visser-Meily JMA, van Vugt M, van den Wijngaard CC, Nieuwkerk PT, van Berckel B, Tolboom N, Knoop H. Neuropsychological functioning after COVID-19: minor differences between individuals with and without persistent complaints after SARS-CoV-2 infection. Clin Neuropsychol. 2024 Jul 17:1-16. doi: 10.1080/13854046.2024.2379508. Epub ahead of print.
Verveen A, Nugroho FA, Bucur IG, Wynberg E, van Willigen HDG, Davidovich U, Lok A, Moll van Charante EP, de Bree GJ, de Jong MD, Kootstra N, Claassen T, de Jonge MI, Heskes T, Prins M, Knoop H, Nieuwkerk PT; RECoVERED Study Group. Long-term sequelae of SARS-CoV-2 two years following infection: exploring the interplay of biological, psychological, and social factors. Psychol Med. 2024 Dec 2:1-11. doi: 10.1017/S0033291724002721. Epub ahead of print.
Verburgh ML, Boyd A, Schim van der Loeff MF, Bakker M, Wit FWNM, van der Valk M, Grobben M, van Pul L, Tejjani K, van Rijswijk J, van Gils MJ, Kootstra NA, van der Hoek L, Reiss P; AGEhIV Cohort Study. Similar Limited Protection Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Infection in Vaccinated Individuals With HIV and Comparable Controls. Open Forum Infect Dis. 2024 Jul 8;11(7):ofae380. doi: 10.1093/ofid/ofae380. PMCID: PMC11273239.
Vink M, Coppoolse H, Bergmans A, Wennekes M, Pas S, Pattipeilohy-van Ommen J, Braks M, Bruisten S, Galimont-Collen A, Wintermans B, Fanoy E. Exploring transmission dynamics of the Sarcoptes scabiei mite in humans by combining molecular typing and epidemiological variables, the Netherlands 2016-2023. Parasit Vectors. 2024 Oct 7;17(1):419. doi: 10.1186/s13071-024-06488-y. PMCID: PMC11459799.
Visser M, Hoebe CJPA, Wolffs PFG, Heijne JCM. Anorectal Neisseria gonorrhoeae infections in women with an3840461d without reported anal sex and sex workers in sexual health centres in the Netherlands: a retrospective cohort study. Lancet Microbe. 2024 Feb 12:S2666-5247(23)00376-2. doi: 10.1016/S2666-5247(23)00376-2. Epub ahead of print.
Visser M, Hoebe CJPA, Wolffs PFG, Heijne JCM. Rectal gonorrhoea in women: true infections?-Authors’ reply. Lancet Microbe. 2024 Jul 19:100932. doi: 10.1016/S2666-5247(24)00174-5. Epub ahead of print.
Vogels CBF, Hill V, Breban MI, Chaguza C, Paul LM, Sodeinde A, Taylor-Salmon E, Ott IM, Petrone ME, Dijk D, Jonges M, Welkers MRA, Locksmith T, Dong Y, Tarigopula N, Tekin O, Schmedes S, Bunch S, Cano N, Jaber R, Panzera C, Stryker I, Vergara J, Zimler R, Kopp E, Heberlein L, Herzog KS, Fauver JR, Morrison AM, Michael SF, Grubaugh ND. DengueSeq: a pan-serotype whole genome amplicon sequencing protocol for dengue virus. BMC Genomics. 2024 May 1;25(1):433. doi: 10.1186/s12864-024-10350-x.PMCID: PMC11062901.
Wahome E, Otieno FO, Kimani J, Boyd A, Okall D, Nzioka J, Gichuru E, van der Elst E, Mehta SD, Bailey RC, Graham SM, Sanders EJ; for the Tatu Pamoja (three-site) study group. Impact of coronavirus disease 2019-related clinic closures on HIV incidence in young adult MSM and transgender women in Kenya. AIDS. 2024 Mar 1;38(3):407-413. doi: 10.1097/QAD.0000000000003782. Epub 2023 Nov 27. PMCID: PMC10842664.
Wei F, Gaisa MM, D’Souza G, Xia N, Giuliano AR, Hawes SE, Gao L, Cheng SH, Donà MG, Goldstone SE, Schim van der Loeff MF, Neukam K, Meites E, Poynten IM, Dai J, Combes JD, Wieland U, Burgos J, Wilkin TJ, Hernandez AL, Iribarren Díaz M, Hidalgo-Tenorio C, Valencia Arredondo M, Nyitray AG, Wentzensen N, Chow EP, Smelov V, Nowak RG, Phanuphak N, Woo YL, Choi Y, Hu Y, Schofield AM, Woestenberg PJ, Chikandiwa AT, Hickey AC, de Pokomandy A, Murenzi G, Péré H, Del Pino M, Ortiz AP, Charnot-Katsikas A, Liu X, Chariyalertsak S, Strong C, Ong JJ, Yunihastuti E, Etienney I, Ferré VM, Zou H, Segondy M, Chinyowa S, Alberts CJ, Clifford GM. Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studies. Lancet HIV. 2021 Sep;8(9):e531-e543. doi: 10.1016/S2352-3018(21)00108-9. Epub 2021 Jul 30. PMCID: PMC8408042.
Wehrli S, Irrgang C, Scott M, Arnrich B, Boender TS. The role of the (in)accessibility of social media data for infodemic management: a public health perspective on the situation in the European Union in March 2024. Front Public Health. 2024 Apr 8;12:1378412. doi: 10.3389/fpubh.2024.1378412. PMCID: PMC11033458.
Wijstma E, Jongen VW, Boyd A, de Vries HJC, Loeff MFSV, Prins M, Hoornenborg E. Outcomes of a policy to prioritize populations with expected healthcare barriers for subsidized PrEP care in Amsterdam, the Netherlands: a cross-sectional study. AIDS. 2024 Sep 30. doi: 10.1097/QAD.0000000000004027. Epub ahead of print.
Wijstma ES, Vanbellinghen MC, van der Loeff MFS. Treatment-as-prevention and HIV incidence in men who have sex with men. Lancet HIV. 2024 Apr;11(4):e207. doi: 10.1016/S2352-3018(24)00058-4.
Wijstma ES, Jongen VW, Boyd A, van den Elshout M, de Vries HJC, Davidovich U, Anderson PL, Prins M, Hoornenborg E, Schim van der Loeff MF. Concordance between daily diary reported PrEP intake and intraerythrocytic tenofovir diphosphate (TFV-DP) in the Amsterdam PrEP demonstration project. AIDS. 2024 Mar 21. doi: 10.1097/QAD.0000000000003889. Epub ahead of print.
Wynberg E, Han AX, van Willigen HDG, Verveen A, van Pul L, Maurer I, van Leeuwen EM, van den Aardweg JG, de Jong MD, Nieuwkerk P, Prins M, Kootstra NA, de Bree GJ; RECoVERED Study Group. Inflammatory profiles are associated with long COVID up to 6 months after COVID-19 onset: A prospective cohort study of individuals with mild to critical COVID-19. PLoS One. 2024 Jul 15;19(7):e0304990. doi: 10.1371/journal.pone.0304990.PMCID: PMC11249251.